Utah last month became the first state in the nation to ban fluoride in public drinking water, joining more than 170 ...

“Using only 10% of the input data from existing systems, Aardvark already outperforms the Global Forecast System (GFS) and is ...

Aardvark, a novel machine learning-based weather prediction system, teases a future where supercomputers are optional for ...

Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome (PWS), with meaningful reductions in hyperphagia (up to a 16 ...

The Aardvark is a funny-looking beast with a long snout that hoovers up food with a pig-like body and thick hide to stymie ...

Aardvark Therapeutics, Inc.’s AARD share price has dipped by 10.73%, which has investors questioning if this is right time to buy.

Aardvark Therapeutics (NASDAQ:AARD – Free Report) had its target price increased by Bank of America from $22.00 to $26.00 in ...

Aardvark bolstered its cash runway through the successful completion of its Initial Public Offering (IPO) in February 2025. SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics ...

The Aardvark was the first airplane to incorporate specific design features to make it multirole capable. When it comes to pioneering aircraft in the U.S. military’s history, the F-111 Aardvark ...

In a report released today, Tim Anderson from Bank of America Securities reiterated a Buy rating on Aardvark Therapeutics, Inc. (AARD – ...